Nference Co., Ltd. is a leading artificial intelligence (AI) company focused on transforming the way healthcare is developed and delivered. Founded in 2013 Murari Aravamdan and Venky SoundararajanThe company develops a suite of cutting-edge products designed to give healthcare professionals the insight and intelligence they need to make better decisions, faster.
Watch Next: This Startup Invents A Programmable Drinkable Plastic That Dissolves In Water In 60 Hours
Nference’s products are based on the company’s AI platform, which leverages machine learning and natural language processing (NLP) algorithms to analyze vast amounts of medical data from a variety of sources. nference hopes to process this data and extract key insights to help healthcare professionals make more informed decisions about patient care, drug development and clinical research.
One of nference’s flagship products is nferX, An AI-powered platform that enables medical professionals to rapidly analyze and interpret large amounts of unstructured clinical data. Previously, physicians manually navigated large volumes of unstructured and non-standardized data sources such as electronic medical records, medical claims data, biomedical literature, clinical records, radiology reports, laboratory results, and other free-form documents. I had to collect. Using advanced NLP techniques, nferX can extract meaningful insights from these busy and distributed data sources. This will enable medical professionals to more easily understand patient conditions, identify potential drug interactions more quickly, and monitor patient outcomes more effectively.
To get the latest on top startup news and investments, visit Sign up for Benzinga’s startup investment and equity crowdfunding newsletter
In addition to nferX, nference has also developed several other products designed to support drug discovery and clinical research. One of these products, nferX Biopharma, is an AI-powered platform that helps drug developers identify promising drug targets, optimize clinical trial design and accelerate the drug development process. Another product, nferX Clinical, is designed to help clinical researchers identify potential patient cohorts for clinical trials based on patient data and other criteria.
Overall, nference is at the forefront of the AI revolution in healthcare, with products helping to transform the way healthcare is delivered. By providing medical professionals with powerful tools and insights, nference helps improve patient outcomes, reduce healthcare costs and accelerate the development of new treatments and cures. As AI technology continues to advance, nference is well positioned and determined to remain a leader in this exciting and rapidly evolving field.
To date, nference has raised $152 million from various investors including A&E Investments, PharmStars and Mayo Clinic.
view the details startup investment from benzinga.
Don’t miss real-time stock alerts – join Benzinga Pro for free! Explore tools that help you invest smarter, faster and better.
This article How AI technology is changing the healthcare industry and who is leading the way? Originally published on Benzinga.com
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. all rights reserved.
